Phase I study of vinorelbine and carboplatin in advanced non-small cell lung cancer

This publication has 17 references indexed in Scilit:

• Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trial
  Annals of Oncology, 1994
• Phase I–II study of vinorelbine (Navelbine®) plus cisplatin in advanced non-small cell lung cancer
  European Journal Of Cancer, 1992
• Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.
  Journal of Clinical Oncology, 1991
• A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung Cancer
  American Journal of Clinical Oncology, 1991
• The calculation of received dose intensity.
  Journal of Clinical Oncology, 1990
• A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer
  New England Journal of Medicine, 1990
• A Phase II Trial of Carboplatin (CBDCA) in Small-Cell and Non-Small-Cell Lung Cancer with Correlation to In Vitro Analysis of Cytotoxicity
  American Journal of Clinical Oncology, 1990
• A randomized trial of three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group
  Cancer Chemotherapy and Pharmacology, 1990
• Carboplatin dosage: prospective evaluation of a simple formula based on renal function.
  Journal of Clinical Oncology, 1989
• Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: A randomized study
  European Journal of Cancer and Clinical Oncology, 1984